The utility of pentraxin 3 and platelet-derived growth factor receptor beta as non-invasive biomarkers for prediction of cardiovascular risk in MAFLD patients

Abstract Background Metabolic-associated fatty liver disease (MAFLD) has emerged as the predominant form of chronic liver disease globally linked with heightened cardiovascular disease (CVD) risk, the leading cause of mortality among affected individuals. Aim This study aims to assess serum PTX3 (pe...

Full description

Bibliographic Details
Main Authors: Hanaa Badran, Maha Elsabaawy, Mahmoud Magdy, Samar Ghanem, Mohammed Said, Mohamed Hamdy Torky, Tamer Samir
Format: Article
Language:English
Published: SpringerOpen 2024-08-01
Series:The Egyptian Journal of Internal Medicine
Subjects:
Online Access:https://doi.org/10.1186/s43162-024-00353-1